Re: JISC/SIRIS "Subject and Institutional Repositories Interactions Study"

From: Alma Swan <a.swan_at_TALK21.COM>
Date: Mon, 1 Dec 2008 12:45:51 +0000

> Ian is correct, especdially in the humanities. Also,
> there is a large amount of STM scholarly output that
> comes from industry, especially the pharmaceutical
> industry

That doesn't change the argument at all:
1. Pharmaceutical research carried out in the industry and not intended for
publication never has been nor will be a focus for OA.
2. Pharmaceutical contract research carried out in universities, paid for
directly and solely by the industry and not intended for publication, never
has been nor will be a focus for OA.
3. Pharmaceutical research sponsored by industry, carried out in
universities and deemed publishable IS a focus for an institutional mandate,
since it is published work from that institution.

Mandates cannot, of course, be applied to the pharmaceutical industry, even
for research it permits to be published. Happily, however, some pharma
companies are now providing OA to their published (and some unpublished)
research findings, notably Novartis, which has made its diabetes research
results OA for some time now and is currently building an OA repository to
house the publishable output of more of its research programmes.

Alma Swan
Key Perspectives Ltd
Truro, UK
Received on Mon Dec 01 2008 - 12:46:54 GMT